AMY YORK: Open Payments
NPI 1962580985 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$583 in 25 payments from 16 companies in 2025. Trend: 2023 $425 · 2024 $445 · 2025 $583
Food & beverage: $583
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $183 |
| Dexcom, Inc. | 3 | $68 |
| Eisai Inc. | 2 | $53 |
| Lilly USA, LLC | 2 | $43 |
| Novo Nordisk Inc | 2 | $36 |
| PFIZER INC. | 2 | $29 |
| Boston Scientific Corporation | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Medtronic, Inc. | 1 | $18 |
Products named: QULIPTA, Dexcom G6 Transmitter, Leqembi, VRAYLAR, MOUNJARO, ELIQUIS, WATCHMAN FLX, Ozempic.
Industry payments across SC — which companies pay providers there.
